Armata Pharmaceuticals (ARMP) Operating Expenses (2016 - 2018)
Historic Operating Expenses for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to $2.8 million.
- Armata Pharmaceuticals' Operating Expenses rose 1714.88% to $2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was $8.1 million, marking a year-over-year decrease of 5042.71%. This contributed to the annual value of $47.6 million for FY2024, which is 482.4% up from last year.
- Per Armata Pharmaceuticals' latest filing, its Operating Expenses stood at $2.8 million for Q4 2018, which was up 1714.88% from $2.4 million recorded in Q3 2018.
- Armata Pharmaceuticals' Operating Expenses' 5-year high stood at $11.9 million during Q4 2016, with a 5-year trough of $784000.0 in Q3 2017.
- Its 5-year average for Operating Expenses is $3.9 million, with a median of $2.8 million in 2018.
- Per our database at Business Quant, Armata Pharmaceuticals' Operating Expenses skyrocketed by 28741.85% in 2016 and then plummeted by 7993.44% in 2017.
- Armata Pharmaceuticals' Operating Expenses (Quarter) stood at $2.7 million in 2014, then increased by 13.71% to $3.1 million in 2015, then surged by 287.42% to $11.9 million in 2016, then tumbled by 79.93% to $2.4 million in 2017, then increased by 17.15% to $2.8 million in 2018.
- Its last three reported values are $2.8 million in Q4 2018, $2.4 million for Q3 2018, and $2.8 million during Q2 2018.